Article
Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
The Journal of infectious diseases - 15 Apr 2013
Schvoerer Evelyne, Moenne-Loccoz Rémy, Murray John M, Velay Aurélie, Turek Marine, Fofana Isabel, Fafi-Kremer Samira, Erba Anne-Claire, Habersetzer François, Doffoël Michel, Gut Jean-Pierre, Donlin Maureen J, Tavis John E, Zeisel Mirjam B, Stoll-Keller Françoise, Baumert Thomas F
Abstract excerpt
BACKGROUND: A major challenge for antiviral treatment of hepatitis C virus (HCV) infection is viral resistance, potentially resulting from the high variability of HCV envelope glycoproteins and subsequent selection of strains with enhanced infectivity and/or immune escape. METHODS: We used a bioinformatics and functional approach to investigate whether E1/E2 envelope glycoprotein structure and function were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
